Concepedia

V. Magdolen

VM

Statistics

Publications

5

Citations

123

H-Index

5

Active since

2000

Affiliations

Klinikum rechts der Isar(Current)

V. Magdolen is an author at Klinikum rechts der Isar specializing in medicine, immunology, and immunotherapy.

Top concepts

Publications per year

2000–2004

5

Publications

5

Combination of an Src Kinase Inhibitor with a Novel Pharmacological Antagonist of the Urokinase Receptor Diminishes <b> <i>in Vitro</i> </b> Colon Cancer Invasiveness

Douglas D. Boyd, Heng Wang, Héctor Martínez Ávila et al. · Clinical Cancer Research · 2004 · 36 citations

High Level Synthesis of Recombinant Soluble Urokinase Receptor (CD87) by Ovarian Cancer Cells Reduces Intraperitoneal Tumor Growth and Spread in Nude Mice

Veronika Lutz, Ute Reuning, Achim Krüger et al. · Biological Chemistry · 2001 · 32 citations

A rapid and versatile method for harnessing scFv antibody fragments with various biological effector functions

Wijnand Helfrich, Hidde J. Haisma, V. Magdolen et al. · Journal of Immunological Methods · 2000 · 22 citations

, , +6

Inhibition of Intraperitoneal Tumor Growth of Human Ovarian Cancer Cells by Bi- and Trifunctional Inhibitors of Tumor-Associated Proteolytic Systems

Janna Krol, Charlotte Kopitz, Angela Kirschenhofer et al. · Biological Chemistry · 2003 · 20 citations

New ELISA for quantitation of human urokinase receptor (CD87) in cancer.

Matthias Kotzsch, Thomas Luther, Nadia Harbeck et al. · International Journal of Oncology · 2000 · 13 citations

, , +18

1–5 of 5